Image

UMMID Programme: India Mission to Tackle Rare Genetic Disorders

UMMID Programme: India Mission to Tackle Rare Genetic Disorders

Overview

The UMMID (Unique Methods of Management of Inherited Disorders) Programme is India’s major national initiative to improve the diagnosis, prevention, and management of inherited genetic disorders. Launched by the Department of Biotechnology (DBT) in 2019, the programme focuses on affordable healthcare, early detection, genetic counselling, and public awareness. It has established nearly 30 NIDAN Kendras across the country to provide advanced genetic testing and counselling services, especially in underserved regions.


UMMID Programme Dedicated to the Nation

On 21 May 2026, Union Minister Jitendra Singh officially dedicated the UMMID Programme to the nation during a special event in New Delhi. During the event, the government also launched the UMMID Dashboard and released the UMMID Compendium to strengthen nationwide monitoring and awareness.

The Minister highlighted that genomic and precision medicine will play a major role in shaping India’s future healthcare system. He also noted that the programme has already benefited nearly three lakh individuals through screening, diagnosis, and outreach activities in aspirational districts and remote regions.


What Is the UMMID Programme?

UMMID stands for Unique Methods of Management of Inherited Disorders . It is a national initiative launched on 23 September 2019 by the Department of Biotechnology under the Ministry of Science and Technology.

The programme was designed to create a complete system for handling inherited and rare genetic disorders through:

  • Early diagnosis
  • Prenatal testing
  • Newborn screening
  • Genetic counselling
  • Public awareness
  • Training of healthcare professionals

The core idea behind the programme is simple: “Prevention is better than cure.”


Why Is the Programme Important?

Genetic and inherited disorders have remained a serious but neglected healthcare challenge in India for many years. Many families spend years searching for proper diagnosis and treatment because testing facilities are limited and treatment costs are extremely high.

India faces a higher burden of genetic disorders due to:

  • Large population size
  • High birth rate
  • Limited awareness
  • Consanguineous marriages in some communities

Congenital and genetic disorders are among the leading causes of newborn mortality in urban India. Experts estimate that genetic disorders account for nearly 80% of rare diseases. This made it necessary to build a strong national healthcare framework focused on prevention and early detection.


Three Major Pillars of the UMMID Programme

1. NIDAN Kendras

NIDAN stands for National Inherited Diseases Administration Kendras . These centres are established in government hospitals to provide:

  • Prenatal testing
  • Newborn screening
  • Genetic counselling
  • Diagnostic services for inherited disorders

Nearly 30 NIDAN Kendras have been developed under the programme. These centres help bring advanced genomic healthcare facilities beyond major metropolitan cities and improve access for ordinary families.


2. Outreach in Aspirational Districts

The programme also focuses on screening pregnant women and newborn babies in aspirational districts. Each diagnostic centre adopts one district to support awareness and prevention programmes.

Special attention is given to diseases such as:

  • Beta-thalassemia
  • Genetic metabolic disorders
  • Other inherited diseases

This outreach model helps doctors and local communities better understand genetic disorders and encourages early intervention.


3. Training and Capacity Building

UMMID aims to develop skilled professionals in fields such as:

  • Molecular Genetics
  • Clinical Genetics
  • Cytogenetics
  • Biochemical Genetics

Training is provided through leading institutions including:

  • All India Institute of Medical Sciences
  • Christian Medical College
  • Sanjay Gandhi Postgraduate Institute of Medical Sciences
  • Centre for DNA Fingerprinting and Diagnostics

These centres help strengthen India’s healthcare workforce in the field of genetic medicine.


Major Achievements of UMMID

The programme has already shown encouraging results across the country.

Key achievements include:

  • Nearly 3 lakh individuals benefited
  • More than 60,000 antenatal screenings completed
  • Over 33,000 newborns screened for genetic disorders
  • Nearly 30 NIDAN Kendras established nationwide

The initiative has successfully created a coordinated national framework connecting diagnostics, counselling, screening, training, and community outreach.


Connection with the National Policy for Rare Diseases 2021

UMMID supports the implementation of the National Policy for Rare Diseases (NPRD), 2021 introduced by the Ministry of Health and Family Welfare.

The policy focuses on:

  • Financial assistance for rare disease patients
  • Better diagnosis and treatment systems
  • Research and development for therapies

UMMID strengthens this policy by building structured systems for early screening, diagnosis, and patient care related to inherited disorders.


UMMID and the Future of Precision Medicine

The programme is also preparing India for the future of precision medicine. The experience gained through UMMID may help doctors create personalised treatments based on genetic profiles for diseases such as:

  • Diabetes
  • Heart disease
  • Cancer

This initiative is expected to play a major role in developing genome-based healthcare systems in the coming decades.


Exam-Oriented Quick Facts

Topic Details
Full Form Unique Methods of Management of Inherited Disorders
Launch Year 2019
Launch Date 23 September 2019
Nodal Ministry Department of Biotechnology, Ministry of Science & Technology
Main Objective Early diagnosis and prevention of inherited disorders
NIDAN Full Form National Inherited Diseases Administration Kendras
Main Concept Prevention is better than cure
Key Focus Prenatal testing, newborn screening, counselling
Linked Policy National Policy for Rare Diseases 2021
Beneficiaries Nearly 3 lakh individuals

Frequently Asked Questions (FAQs)

Q1. What does UMMID stand for?

UMMID stands for Unique Methods of Management of Inherited Disorders.

Q2. Which ministry launched the UMMID Programme?

The programme was launched by the Department of Biotechnology under the Ministry of Science and Technology.

Q3. What are NIDAN Kendras?

NIDAN Kendras are government hospital-based centres that provide genetic testing, prenatal diagnosis, newborn screening, and counselling services.

Q4. How many people have benefited from the programme?

Nearly three lakh individuals have benefited through screening and diagnostic services.

Q5. Which policy is supported by UMMID?

Month: 

Category: